Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000888002-07-000504
Filing Date
2007-02-13
Accepted
2007-02-13 15:19:12
Documents
2
Group Members
ALLIANCEBERNSTEIN L.P.AXAAXA ASSURANCES I.A.R.D. MUTUELLEAXA ASSURANCES VIE MUTUELLEAXA COURTAGE ASSURANCE MUTUELLEAXA-EQUITABLE LIFE INSURANCE COMPANY

Document Format Files

Seq Description Document Type Size
1 teva1231_g.txt SC 13G/A 17225
2 JOINT FILING AGREEMENT teva1231_e.txt EX-24 1162
  Complete submission text file 0000888002-07-000504.txt   20703
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131
TEVA PHARMACEUTICAL INDUSTRIES LTD (Subject) CIK: 0000818686 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-55457 | Film No.: 07609457
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1290 AVENUE OF THE AMERICAS NEW YORK NY 10104
Business Address 1290 AVENUE OF THE AMERICAS NEW YORK NY 10104 2125541234
AXA FINANCIAL INC (Filed by) CIK: 0000888002 (see all company filings)

EIN.: 133623351 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6311 Life Insurance